Sandoz Group AG

Sandoz Group AG logo
🇩🇪Germany
Ownership
Public
Established
1986-01-01
Employees
20K
Market Cap
$19B
Website
http://www.sandoz.com

Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients With Postmenopausal Osteoporosis

First Posted Date
2019-06-04
Last Posted Date
2023-03-08
Lead Sponsor
Sandoz
Target Recruit Count
527
Registration Number
NCT03974100
Locations
🇪🇸

Sandoz Investigational Site, Sevilla, Spain

Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease

Completed
Conditions
First Posted Date
2019-03-26
Last Posted Date
2021-06-18
Lead Sponsor
Sandoz
Target Recruit Count
63
Registration Number
NCT03890445
Locations
🇸🇪

Sandoz Investigational Site, Orebro, Sweden

Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery

First Posted Date
2018-05-22
Last Posted Date
2019-11-06
Lead Sponsor
Sandoz
Target Recruit Count
381
Registration Number
NCT03531697
Locations
🇨🇦

Sandoz Investigative Site, Multiple Locations, Canada

A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia

Phase 1
Completed
Conditions
Interventions
First Posted Date
2018-01-16
Last Posted Date
2019-05-30
Lead Sponsor
Sandoz
Target Recruit Count
71
Registration Number
NCT03399084
Locations
🇺🇸

Sandoz Investigative Site, Miami, Florida, United States

A Local Clinical Study for the Comparative Evaluation of Efficacy and Safety of Angal, Lozenges [Menthol] and ANTI-ANGIN® FORMULA, Lozenges, in Treatment of Patients With a Sore Throat

First Posted Date
2017-03-29
Last Posted Date
2019-03-22
Lead Sponsor
Sandoz
Target Recruit Count
228
Registration Number
NCT03095521
Locations
🇷🇺

Sandoz Investigational Site, Stavropol', Russian Federation

A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.

First Posted Date
2016-09-30
Last Posted Date
2019-03-25
Lead Sponsor
Sandoz
Target Recruit Count
28
Registration Number
NCT02920242
Locations
🇲🇽

Sandoz Investigative Site, Mexico City, Mexico

Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis

First Posted Date
2016-04-20
Last Posted Date
2018-12-19
Lead Sponsor
Sandoz
Target Recruit Count
353
Registration Number
NCT02744755
Locations
🇺🇸

Joao Nascimento (Private Practice), Bridgeport, Connecticut, United States

🇺🇸

Arthritis & Rheumatic Disease Specialties, Aventura, Florida, United States

🇺🇸

RASF - Clinical Research Center, Boca Raton, Florida, United States

and more 80 locations

Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis

Phase 3
Completed
Conditions
Interventions
First Posted Date
2015-12-23
Last Posted Date
2018-09-19
Lead Sponsor
Sandoz
Target Recruit Count
376
Registration Number
NCT02638259
Locations
🇬🇧

Novartis Investigative Site, London, United Kingdom

GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®

First Posted Date
2015-08-04
Last Posted Date
2017-12-28
Lead Sponsor
Sandoz
Target Recruit Count
107
Registration Number
NCT02514772
Locations
🇺🇸

Physician Research Collaboration, LLC, Lincoln, Nebraska, United States

🇺🇸

Physicians East, PA, Greenville, North Carolina, United States

🇺🇸

Omega Research Consultants, LLC, Orlando, Florida, United States

and more 60 locations
© Copyright 2024. All Rights Reserved by MedPath